Evidence map›Paper›PMID 33164723›Full record

ArticleJournal of managed care & specialty pharmacy2021

Economic value of nonsurgical weight loss in adults with obesity.

Yuchen Ding, Xiaozhou Fan, Christopher M Blanchette, B Gabriel Smolarz, Wayne Weng, Abhilasha Ramasamy

Open access · bronzeAbstract read
In one paragraph

Article in Journal of managed care & specialty pharmacy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Relative Value of Anti-Obesity Medications Compared to Similar Therapies.ClinicoEconomics and outcomes research : CEOR · 2023
    Article
  11. Article
  12. Article
  13. Specialized Medical Weight Management Intervention for High-Risk Obesity.Journal of health economics and outcomes research · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yuchen DingHealth Economics and Outcomes Research, Novo Nordisk, Plainsboro, NJ.
Xiaozhou FanHEOR Real World Data Analytics, Novo Nordisk, Plainsboro, NJ.
Christopher M BlanchetteHEOR Strategy and Evidence Generation, Novo Nordisk, Plainsboro, NJ.
B Gabriel SmolarzUS Medical Affairs, Novo Nordisk, Plainsboro, NJ.
Wayne WengHEOR Real World Data Analytics, Novo Nordisk, Plainsboro, NJ.
Abhilasha RamasamyHEOR Strategy and Evidence Generation, Novo Nordisk, Plainsboro, NJ.
Novo Nordisk (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Health Care CostsAdolescentAdultCohort StudiesCost SavingsFemaleHumansInsurance Claim ReviewMaleMiddle AgedObesityRetrospective StudiesUnited StatesWeight LossYoung Adult

Identifiers

PMID33164723
PMCPMC10394211
OpenAlexW3103690713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.